Europe Radioimmunoassay Market By Type (Reagents & Kits, Analyzers), by Application (Research, Clinical Diagnostics), by End User (Hospital, Pharmaceuticals Industry & CRO, Academics, Clinical Diagnostic Laboratories, Others), & By Geography-Analysis & Forecast to 2020
The research report categorizes the Europe radioimmunoassay (RIA) market by type into two segments: analyzers and reagents & kits. Based on application, the market has been segmented into research and clinical diagnostics, providing exhaustive value analysis for 2014 as well as forecast up to 2020. The end users include hospitals, clinical diagnostics labs, academics, pharmaceutical industry and CRO, & others. The market is comprehensively analyzed at a granular level based on geography, into Germany, France, U.K., Italy, Spain, and Rest of the Europe to provide in-depth information.
The technique of radioimmunoassay (RIA) is advanced and sensitive enough to find small molecules in the blood, and is therefore used for research purposes and diagnosis of diseases, such as cancer. This technique is also implemented by organizations and research labs for research purposes using serum from animals or humans. The new range of immunoassay kits and analyzers provide remedies for autoimmune diseases, such as diabetes. These are widely used in the process of drug discovery and screening in blood banks.
Radioimmunoassay (RIA) is one of the pivotal and traditional methods used for the testing of endocrinological disorders. RIA also has prominent usage in the field of neurodegenerative disorders. In spite of the high precision, robust nature, and impeccable sensitivity, the global radioimmunoassay (RIA) market has been witnessing a slow growth in terms of market values and kit volumes. This can be attributed to the paradigm shift in the adoption of alternatives, such as, ELISA, chemiluminescence assay, immunofluorescence assay, & other non-radio techniques and lack of automation.
In Europe, many clinical laboratories are taking measures to remove RIA tests off their shelf; ELISA has been instrumental in taking over the RIA tests. European Greens has been instrumental in maintaining environmental responsibility across geographies. The utilization of radioactive substances in RIA procedures poses a threat to environment and human health. Thus, the political scenario has negatively impacted the use of RIA tests in Europe due to the conscious effort from the European Greens. In spite of the above-mentioned dynamics, Europe captures a major market share in RIA globally. Majority of the RIA manufacturers are based out of Europe, thus claiming a strong footprint in Europe.
In-depth market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports and interviews with industry experts, key opinion leaders such as CEOs, directors, and marketing executives. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. The major players in the radioimmunoassay are IBL International (A Tecan Company) (Germany), Cisbio (France), DiaSorin S.p.A. (Italy), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany), Euro Diagnostica AB (Sweden), DIAsource ImmunoAssays SA (Belgium), PerkinElmer, Inc. (U.S.), MP Biomedicals, LLC (U.S.), DRG International, Inc. (U.S.), & Beckman Coulter, Inc. (U.S.).
The technique of radioimmunoassay (RIA) is advanced and sensitive enough to find small molecules in the blood, and is therefore used for research purposes and diagnosis of diseases, such as cancer. This technique is also implemented by organizations and research labs for research purposes using serum from animals or humans. The new range of immunoassay kits and analyzers provide remedies for autoimmune diseases, such as diabetes. These are widely used in the process of drug discovery and screening in blood banks.
Radioimmunoassay (RIA) is one of the pivotal and traditional methods used for the testing of endocrinological disorders. RIA also has prominent usage in the field of neurodegenerative disorders. In spite of the high precision, robust nature, and impeccable sensitivity, the global radioimmunoassay (RIA) market has been witnessing a slow growth in terms of market values and kit volumes. This can be attributed to the paradigm shift in the adoption of alternatives, such as, ELISA, chemiluminescence assay, immunofluorescence assay, & other non-radio techniques and lack of automation.
In Europe, many clinical laboratories are taking measures to remove RIA tests off their shelf; ELISA has been instrumental in taking over the RIA tests. European Greens has been instrumental in maintaining environmental responsibility across geographies. The utilization of radioactive substances in RIA procedures poses a threat to environment and human health. Thus, the political scenario has negatively impacted the use of RIA tests in Europe due to the conscious effort from the European Greens. In spite of the above-mentioned dynamics, Europe captures a major market share in RIA globally. Majority of the RIA manufacturers are based out of Europe, thus claiming a strong footprint in Europe.
In-depth market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports and interviews with industry experts, key opinion leaders such as CEOs, directors, and marketing executives. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. The major players in the radioimmunoassay are IBL International (A Tecan Company) (Germany), Cisbio (France), DiaSorin S.p.A. (Italy), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany), Euro Diagnostica AB (Sweden), DIAsource ImmunoAssays SA (Belgium), PerkinElmer, Inc. (U.S.), MP Biomedicals, LLC (U.S.), DRG International, Inc. (U.S.), & Beckman Coulter, Inc. (U.S.).
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF THE RADIOIMMUNOASSAY (RIA) MARKET
2.2 ARRIVING AT THE RADIOIMMUNOASSAY (RIA) MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 MACRO INDICATOR-BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 RADIOIMMUASSAY (RIA) MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
5 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE
5.1 INTRODUCTION
5.2 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET
5.3 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET
6 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END USER
6.1 INTRODUCTION
6.2 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN HOSPITALS
6.3 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO
6.4 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS
6.5 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES
7 RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY
7.3 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY
7.4 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION
7.5 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY
7.6 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY
7.7 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY
8 EUROPE RADIOIMMUNOASSAY MARKET, BY GEOGRAPHY
8.1 INTRODUCTION
8.1.1 GERMANY RADIOIMMUNOASSAY (RIA) MARKET
8.1.2 FRANCE RADIOIMMUNOASSAY (RIA) MARKET
8.1.3 U.K. RADIOIMMUNOASSAY (RIA) MARKET
8.1.4 ITALY RADIOIMMUNOASSAY (RIA) MARKET
8.1.5 SPAIN RADIOIMMUNOASSAY (RIA) MARKET
9 EUROPE RADIOIMMUNOASSAY MARKET: COMPETITIVE LANDSCAPE
9.1 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: COMPANY SHARE ANALYSIS
10 EUROPE RADIOIMMUNOASSAY MARKET, BY COMPANY
10.1 DIASORIN S.P.A.
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCTS AND SERVICE OFFERINGS
10.1.4 RECENT DEVELOPMENT
10.1.5 MMM VIEW
10.2 EURO DIAGNOSTICA AB
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCTS AND SERVICE OFFERINGS
10.2.4 RECENT DEVELOPMENT
10.2.5 MMM VIEW
10.3 MERCK MILLIPORE CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCTS AND SERVICE OFFERINGS
10.3.4 RECENT DEVELOPMENT
10.3.5 MMM VIEW
10.4 DIASOURCE IMMUNOSSAYS S.A
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCTS AND SERVICE OFFERINGS
10.4.4 RECENT DEVELOPMENT
10.4.5 MMM VIEW
10.5 STRATEC BIOMEDICALS AG
10.5.1 OVERVIEW
10.5.2 KEY FINANCIALS
10.5.3 PRODUCT AND SERVICE OFFERINGS
10.5.4 RELATED DEVELOPMENTS
10.5.5 MMM VIEW
10.6 BERTHOLD TECHNOLOGIES GMBH & CO. KG
10.6.1 OVERVIEW
10.6.2 KEY FINANCIALS
10.6.3 PRODUCT AND SERVICE OFFERINGS
10.6.4 RELATED DEVELOPMENTS
10.4. MMM VIEW
10.7 IZOTOP
10.7.1 OVERVIEW
10.7.2 KEY FINANCIALS
10.7.3 PRODUCT AND SERVICE OFFERINGS
10.7.4 RELATED DEVELOPMENTS
10.7.5 MMM VIEW
10.8 BECKMAN COULTER, INC.
10.8.1 OVERVIEW
10.8.2 KEY FINANCIALS
10.8.3 PRODUCT AND SERVICE OFFERINGS
10.8.4 RELATED DEVELOPMENTS
10.8.5 MMM ANALYSIS
10.9 CISBIO
10.9.1 OVERVIEW
10.9.2 KEY FINANCIALS
10.9.3 PRODUCT AND SERVICE OFFERINGS
10.9.4 RELATED DEVELOPMENTS
10.9.5 MMM VIEW
10.10 MP BIOMEDICALS LLC
10.10.1 OVERVIEW
10.10.2 KEY FINANCIALS
10.10.3 PRODUCT AND SERVICE OFFERINGS
10.10.4 RELATED DEVELOPMENTS
10.10.5 MMM VIEW
10.11 PERKINELMER, INC.
10.11.1 OVERVIEW
10.11.2 KEY FINANCIALS
10.11.3 PRODUCT AND SERVICE OFFERINGS
10.11.4 RELATED DEVELOPMENTS
10.11.5 MMM VIEW
10.12 IBL INTERNATIONAL (A TECAN COMPANY)
10.12.1 OVERVIEW
10.12.2 KEY FINANCIALS
10.12.3 PRODUCT AND SERVICE OFFERINGS
10.12.4 RELATED DEVELOPMENTS
10.12.5 MMM VIEW
10.13 DRG INTERNATIONAL, INC.
10.13.1 OVERVIEW
10.13.2 KEY FINANCIALS
10.13.3 PRODUCT AND SERVICE OFFERINGS
10.13.4 RELATED DEVELOPMENTS
10.13.5 MMM VIEW
11 APPENDIX
11.1 CUSTOMIZATION OPTIONS
11.1.1 PRODUCT ANALYSIS
11.1.2 BRAND/PRODUCT PERCEPTION MATRIX
11.1.3 PORTER’S FIVE FORCES ANALYSIS
11.2 RELATED REPORTS
11.3 RT SNAPSHOT
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF THE RADIOIMMUNOASSAY (RIA) MARKET
2.2 ARRIVING AT THE RADIOIMMUNOASSAY (RIA) MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 MACRO INDICATOR-BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 RADIOIMMUASSAY (RIA) MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
5 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE
5.1 INTRODUCTION
5.2 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET
5.3 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET
6 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END USER
6.1 INTRODUCTION
6.2 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN HOSPITALS
6.3 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO
6.4 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS
6.5 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES
7 RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY
7.3 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY
7.4 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION
7.5 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY
7.6 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY
7.7 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY
8 EUROPE RADIOIMMUNOASSAY MARKET, BY GEOGRAPHY
8.1 INTRODUCTION
8.1.1 GERMANY RADIOIMMUNOASSAY (RIA) MARKET
8.1.2 FRANCE RADIOIMMUNOASSAY (RIA) MARKET
8.1.3 U.K. RADIOIMMUNOASSAY (RIA) MARKET
8.1.4 ITALY RADIOIMMUNOASSAY (RIA) MARKET
8.1.5 SPAIN RADIOIMMUNOASSAY (RIA) MARKET
9 EUROPE RADIOIMMUNOASSAY MARKET: COMPETITIVE LANDSCAPE
9.1 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: COMPANY SHARE ANALYSIS
10 EUROPE RADIOIMMUNOASSAY MARKET, BY COMPANY
10.1 DIASORIN S.P.A.
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCTS AND SERVICE OFFERINGS
10.1.4 RECENT DEVELOPMENT
10.1.5 MMM VIEW
10.2 EURO DIAGNOSTICA AB
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCTS AND SERVICE OFFERINGS
10.2.4 RECENT DEVELOPMENT
10.2.5 MMM VIEW
10.3 MERCK MILLIPORE CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCTS AND SERVICE OFFERINGS
10.3.4 RECENT DEVELOPMENT
10.3.5 MMM VIEW
10.4 DIASOURCE IMMUNOSSAYS S.A
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCTS AND SERVICE OFFERINGS
10.4.4 RECENT DEVELOPMENT
10.4.5 MMM VIEW
10.5 STRATEC BIOMEDICALS AG
10.5.1 OVERVIEW
10.5.2 KEY FINANCIALS
10.5.3 PRODUCT AND SERVICE OFFERINGS
10.5.4 RELATED DEVELOPMENTS
10.5.5 MMM VIEW
10.6 BERTHOLD TECHNOLOGIES GMBH & CO. KG
10.6.1 OVERVIEW
10.6.2 KEY FINANCIALS
10.6.3 PRODUCT AND SERVICE OFFERINGS
10.6.4 RELATED DEVELOPMENTS
10.4. MMM VIEW
10.7 IZOTOP
10.7.1 OVERVIEW
10.7.2 KEY FINANCIALS
10.7.3 PRODUCT AND SERVICE OFFERINGS
10.7.4 RELATED DEVELOPMENTS
10.7.5 MMM VIEW
10.8 BECKMAN COULTER, INC.
10.8.1 OVERVIEW
10.8.2 KEY FINANCIALS
10.8.3 PRODUCT AND SERVICE OFFERINGS
10.8.4 RELATED DEVELOPMENTS
10.8.5 MMM ANALYSIS
10.9 CISBIO
10.9.1 OVERVIEW
10.9.2 KEY FINANCIALS
10.9.3 PRODUCT AND SERVICE OFFERINGS
10.9.4 RELATED DEVELOPMENTS
10.9.5 MMM VIEW
10.10 MP BIOMEDICALS LLC
10.10.1 OVERVIEW
10.10.2 KEY FINANCIALS
10.10.3 PRODUCT AND SERVICE OFFERINGS
10.10.4 RELATED DEVELOPMENTS
10.10.5 MMM VIEW
10.11 PERKINELMER, INC.
10.11.1 OVERVIEW
10.11.2 KEY FINANCIALS
10.11.3 PRODUCT AND SERVICE OFFERINGS
10.11.4 RELATED DEVELOPMENTS
10.11.5 MMM VIEW
10.12 IBL INTERNATIONAL (A TECAN COMPANY)
10.12.1 OVERVIEW
10.12.2 KEY FINANCIALS
10.12.3 PRODUCT AND SERVICE OFFERINGS
10.12.4 RELATED DEVELOPMENTS
10.12.5 MMM VIEW
10.13 DRG INTERNATIONAL, INC.
10.13.1 OVERVIEW
10.13.2 KEY FINANCIALS
10.13.3 PRODUCT AND SERVICE OFFERINGS
10.13.4 RELATED DEVELOPMENTS
10.13.5 MMM VIEW
11 APPENDIX
11.1 CUSTOMIZATION OPTIONS
11.1.1 PRODUCT ANALYSIS
11.1.2 BRAND/PRODUCT PERCEPTION MATRIX
11.1.3 PORTER’S FIVE FORCES ANALYSIS
11.2 RELATED REPORTS
11.3 RT SNAPSHOT
LIST OF TABLES
Table 1 GLOBAL IMMUNOASSAY MARKET SIZE & RADIOIMMUNOASSAY MARKET SIZE, 2014 (USD MILLION)
Table 2 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: COMPARISON WITH PARENT MARKET, 2013–2020 (USD MILLION)
Table 3 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 4 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS AND KITS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 5 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: DRIVERS AND INHIBITORS
Table 6 EUROPE RADIOIMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 7 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 8 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 9 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END-USERS, 2013–2020 (USD MILLION)
Table 10 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN HOSPITALS, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 11 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 12 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 13 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 14 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 15 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 16 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 17 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 18 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 19 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 20 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 21 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Table 22 GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 23 GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 24 FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 25 FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 26 U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 27 U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 28 ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 29 ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 30 SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 31 SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 32 EUROPE RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 33 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 34 DIASORIN S.P.A, REVENUE, 2010-2014 (USD MN)
Table 35 MERCK MILLIPORE CORPORATION, KEY FINANCIALS, 2010-2014 (USD MN)
Table 1 GLOBAL IMMUNOASSAY MARKET SIZE & RADIOIMMUNOASSAY MARKET SIZE, 2014 (USD MILLION)
Table 2 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: COMPARISON WITH PARENT MARKET, 2013–2020 (USD MILLION)
Table 3 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 4 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS AND KITS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 5 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: DRIVERS AND INHIBITORS
Table 6 EUROPE RADIOIMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 7 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 8 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 9 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END-USERS, 2013–2020 (USD MILLION)
Table 10 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN HOSPITALS, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 11 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 12 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 13 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 14 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 15 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 16 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 17 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 18 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 19 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 20 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 21 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Table 22 GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 23 GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 24 FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 25 FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 26 U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 27 U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 28 ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 29 ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 30 SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 31 SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 32 EUROPE RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 33 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 34 DIASORIN S.P.A, REVENUE, 2010-2014 (USD MN)
Table 35 MERCK MILLIPORE CORPORATION, KEY FINANCIALS, 2010-2014 (USD MN)
LIST OF FIGURES
Figure 1 EUROPE RADIOIMMUNOASSAY (RIA) MARKET SEGMENTATION & COVERAGE
Figure 2 RADIOIMMUNOASSAY (RIA) MARKET: INTEGRATED ECOSYSTEM
Figure 3 ARRIVING AT THE RADIOIMMUNOASSAY (RIA) MARKET SIZE
Figure 4 TOP-DOWN APPROACH
Figure 5 MACRO INDICATOR-BASED APPROACH
Figure 6 EUROPE RADIOIMMUNOASSAY (RIA) MARKET SNAPSHOT, 2014
Figure 7 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, COMPARISON WITH PARENT MARKET, 2013-2020 (USD MILLION)
Figure 8 EUROPE RADIOIMMUNOASSAY (RIA) TYPE MARKET, BY GEOGRAPHY, 2014 (USD MILLION)
Figure 9 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013–2020 (USD MILLION)
Figure 10 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 11 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 12 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013–2020 (USD MILLION)
Figure 13 EUROPE RADIOIMMUNOASSAY (RIA) HOSPITALS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 14 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 15 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 16 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 17 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Figure 18 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 19 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 20 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 21 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 22 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 23 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 24 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY GEOGRAPHY, 2014 & 2020
Figure 25 GERMANY RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 26 FRANCE RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 27 U.K. RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW, 2014 & 2020 (%)
Figure 28 ITALY RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%)
Figure 29 SPAIN RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW 2014 & 2020 (%)
Figure 30 EUROPE RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 31 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 32 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: KEY PLAYERS OPERATING IN APPLICATION AREAS
Figure 33 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: COVERAGE OF KEY PLAYERS BY APPLICATION
Figure 34 DIASORIN S.P.A: GEOGRAPHICAL AND BUSINESS REVENUE MIX 2014(%)
Figure 35 DIASORIN S.P.A, REVENUE MIX, 2010-2014 (USD MN)
Figure 36 MERCK MILLIPORE CORPORATION, KEY FINANCIALS, 2010-2014 (USD MN)
Figure 37 STRATEC BIOMEDICAL AG, REVENUE MIX, 2010-2014 (USD MN)
Figure 38 STRATEC BIOMEDICAL AG, REVENUE MIX, 2010-2014 (USD MN)
Figure 39 DANAHER CORPORATIONS: REVENUE MIX, 2014 (%)
Figure 40 PERKINELMER, INC.: REVENUE MIX, 2014 (%)
Figure 41 TECAN TRADING AG: REVENUE MIX, 2014 (%)
Figure 1 EUROPE RADIOIMMUNOASSAY (RIA) MARKET SEGMENTATION & COVERAGE
Figure 2 RADIOIMMUNOASSAY (RIA) MARKET: INTEGRATED ECOSYSTEM
Figure 3 ARRIVING AT THE RADIOIMMUNOASSAY (RIA) MARKET SIZE
Figure 4 TOP-DOWN APPROACH
Figure 5 MACRO INDICATOR-BASED APPROACH
Figure 6 EUROPE RADIOIMMUNOASSAY (RIA) MARKET SNAPSHOT, 2014
Figure 7 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, COMPARISON WITH PARENT MARKET, 2013-2020 (USD MILLION)
Figure 8 EUROPE RADIOIMMUNOASSAY (RIA) TYPE MARKET, BY GEOGRAPHY, 2014 (USD MILLION)
Figure 9 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013–2020 (USD MILLION)
Figure 10 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 11 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 12 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013–2020 (USD MILLION)
Figure 13 EUROPE RADIOIMMUNOASSAY (RIA) HOSPITALS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 14 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 15 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 16 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Figure 17 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Figure 18 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 19 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 20 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 21 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 22 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 23 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Figure 24 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY GEOGRAPHY, 2014 & 2020
Figure 25 GERMANY RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 26 FRANCE RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 27 U.K. RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW, 2014 & 2020 (%)
Figure 28 ITALY RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%)
Figure 29 SPAIN RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW 2014 & 2020 (%)
Figure 30 EUROPE RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 31 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 32 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: KEY PLAYERS OPERATING IN APPLICATION AREAS
Figure 33 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: COVERAGE OF KEY PLAYERS BY APPLICATION
Figure 34 DIASORIN S.P.A: GEOGRAPHICAL AND BUSINESS REVENUE MIX 2014(%)
Figure 35 DIASORIN S.P.A, REVENUE MIX, 2010-2014 (USD MN)
Figure 36 MERCK MILLIPORE CORPORATION, KEY FINANCIALS, 2010-2014 (USD MN)
Figure 37 STRATEC BIOMEDICAL AG, REVENUE MIX, 2010-2014 (USD MN)
Figure 38 STRATEC BIOMEDICAL AG, REVENUE MIX, 2010-2014 (USD MN)
Figure 39 DANAHER CORPORATIONS: REVENUE MIX, 2014 (%)
Figure 40 PERKINELMER, INC.: REVENUE MIX, 2014 (%)
Figure 41 TECAN TRADING AG: REVENUE MIX, 2014 (%)
